Cargando…
Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636297/ http://dx.doi.org/10.1097/01.GOX.0000526177.14165.f4 |
| _version_ | 1783270413650886656 |
|---|---|
| author | Bindewald, Matthew Singla, Sonia Leiman, David Baynton, Barr Minkowitz, Harold S. McCallum, Stewart Mack, Randall Keller, Rosemary Freyer, Alex Du, Wei |
| author_facet | Bindewald, Matthew Singla, Sonia Leiman, David Baynton, Barr Minkowitz, Harold S. McCallum, Stewart Mack, Randall Keller, Rosemary Freyer, Alex Du, Wei |
| author_sort | Bindewald, Matthew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5636297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56362972017-10-17 Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty Bindewald, Matthew Singla, Sonia Leiman, David Baynton, Barr Minkowitz, Harold S. McCallum, Stewart Mack, Randall Keller, Rosemary Freyer, Alex Du, Wei Plast Reconstr Surg Glob Open PSTM 2017 Abstract Supplement Wolters Kluwer Health 2017-10-02 /pmc/articles/PMC5636297/ http://dx.doi.org/10.1097/01.GOX.0000526177.14165.f4 Text en Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | PSTM 2017 Abstract Supplement Bindewald, Matthew Singla, Sonia Leiman, David Baynton, Barr Minkowitz, Harold S. McCallum, Stewart Mack, Randall Keller, Rosemary Freyer, Alex Du, Wei Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title | Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title_full | Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title_fullStr | Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title_full_unstemmed | Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title_short | Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty |
| title_sort | abstract: efficacy and safety of n1539, intravenous meloxicam, in a phase 3 study of subjects with moderate to severe pain following abdominoplasty |
| topic | PSTM 2017 Abstract Supplement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636297/ http://dx.doi.org/10.1097/01.GOX.0000526177.14165.f4 |
| work_keys_str_mv | AT bindewaldmatthew abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT singlasonia abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT leimandavid abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT bayntonbarr abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT minkowitzharolds abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT mccallumstewart abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT mackrandall abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT kellerrosemary abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT freyeralex abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty AT duwei abstractefficacyandsafetyofn1539intravenousmeloxicaminaphase3studyofsubjectswithmoderatetoseverepainfollowingabdominoplasty |